PT3332789T - Cladribine regimen for treating multiple sclerosis - Google Patents
Cladribine regimen for treating multiple sclerosisInfo
- Publication number
- PT3332789T PT3332789T PT181516345T PT18151634T PT3332789T PT 3332789 T PT3332789 T PT 3332789T PT 181516345 T PT181516345 T PT 181516345T PT 18151634 T PT18151634 T PT 18151634T PT 3332789 T PT3332789 T PT 3332789T
- Authority
- PT
- Portugal
- Prior art keywords
- multiple sclerosis
- treating multiple
- cladribine
- regimen
- cladribine regimen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Chemical And Physical Treatments For Wood And The Like (AREA)
- Pressure Welding/Diffusion-Bonding (AREA)
Abstract
The present invention is related to the use of Cladribine for the preparation of a pharmaceutical formulation for the treatment of multiple sclerosis, especially relapsing-remitting multiple sclerosis or early secondary progressive multiple sclerosis, wherein the preparation is to be the orally administered and wherein re-treatments are possible.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04106909 | 2004-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3332789T true PT3332789T (en) | 2022-07-05 |
Family
ID=34930135
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT140019704T PT2805723T (en) | 2004-12-22 | 2005-12-20 | Cladribine regimen for treating multiple sclerosis |
| PT181516345T PT3332789T (en) | 2004-12-22 | 2005-12-20 | Cladribine regimen for treating multiple sclerosis |
| PT05823474T PT1827461E (en) | 2004-12-22 | 2005-12-20 | Cladribine regimen for treating multiple sclerosis |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT140019704T PT2805723T (en) | 2004-12-22 | 2005-12-20 | Cladribine regimen for treating multiple sclerosis |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT05823474T PT1827461E (en) | 2004-12-22 | 2005-12-20 | Cladribine regimen for treating multiple sclerosis |
Country Status (10)
| Country | Link |
|---|---|
| AT (1) | ATE547106T1 (en) |
| DK (1) | DK1827461T3 (en) |
| ES (4) | ES2495392T3 (en) |
| HU (1) | HUE035859T2 (en) |
| LT (1) | LT2805723T (en) |
| ME (1) | ME01333B (en) |
| PT (3) | PT2805723T (en) |
| RS (1) | RS52219B (en) |
| SI (1) | SI1827461T1 (en) |
| UA (1) | UA96260C2 (en) |
-
2005
- 2005-12-20 PT PT140019704T patent/PT2805723T/en unknown
- 2005-12-20 UA UAA200708371A patent/UA96260C2/en unknown
- 2005-12-20 PT PT181516345T patent/PT3332789T/en unknown
- 2005-12-20 DK DK05823474.1T patent/DK1827461T3/en active
- 2005-12-20 ES ES10182676.6T patent/ES2495392T3/en active Active
- 2005-12-20 HU HUE14001970A patent/HUE035859T2/en unknown
- 2005-12-20 ES ES05823474T patent/ES2382554T3/en active Active
- 2005-12-20 ES ES14001970.4T patent/ES2666146T3/en active Active
- 2005-12-20 AT AT05823474T patent/ATE547106T1/en active
- 2005-12-20 ME MEP-2012-35A patent/ME01333B/en unknown
- 2005-12-20 ES ES10182632T patent/ES2428741T3/en active Active
- 2005-12-20 SI SI200531514T patent/SI1827461T1/en unknown
- 2005-12-20 RS RS20120161A patent/RS52219B/en unknown
- 2005-12-20 LT LTEP14001970.4T patent/LT2805723T/en unknown
- 2005-12-20 PT PT05823474T patent/PT1827461E/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2495392T3 (en) | 2014-09-17 |
| ES2382554T3 (en) | 2012-06-11 |
| HUE035859T2 (en) | 2018-05-28 |
| DK1827461T3 (en) | 2012-03-26 |
| ES2666146T3 (en) | 2018-05-03 |
| ATE547106T1 (en) | 2012-03-15 |
| RS52219B (en) | 2012-10-31 |
| SI1827461T1 (en) | 2012-05-31 |
| ME01333B (en) | 2013-12-20 |
| PT2805723T (en) | 2018-01-25 |
| PT1827461E (en) | 2012-05-07 |
| UA96260C2 (en) | 2011-10-25 |
| ES2428741T3 (en) | 2013-11-11 |
| LT2805723T (en) | 2018-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG160391A1 (en) | Cladribine regimen for treating multiple sclerosis | |
| TW200508214A (en) | Novel compounds | |
| TW200722081A (en) | New therapeutic combinations for the treatment or prevention of depression | |
| WO2006063841A3 (en) | Trycyclic heterocycles, their manufacture and use as pharmaceutical agents | |
| RS20090083A (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta -mimetics | |
| IL228952A0 (en) | Pharmaceutical compositions comprising ferric citrate for reducing serum phosphate levels, and use thereof for the preparation of medicaments for treating or ameliorating calcium-associated disorders | |
| WO2003082853A8 (en) | New compounds | |
| TW200806300A (en) | New therapeutic combinations for the treatment of depression | |
| TW200621259A (en) | Chemical compounds | |
| MY148125A (en) | Compounds | |
| WO2007135172A3 (en) | Cladribine regimen for treating multiple sclerosis | |
| SG158863A1 (en) | Intravenous formulations of pde-5 inhibitors | |
| TW200734334A (en) | Treatment of substance abuse | |
| TW200639156A (en) | New compounds | |
| BRPI0513598A (en) | enteric release coated tablet dosage forms | |
| HRP20041092A2 (en) | New pharmaceutical compositions containing filbanserin polymorph a | |
| MX2022013615A (en) | Macrocyclic inhibitors of peptidylarginine deiminases. | |
| UA91694C2 (en) | Use of emodepside and pf1022 for prevention of vertical endoparasite infections | |
| TW200634002A (en) | Chemical compounds | |
| UA104281C2 (en) | Antitumoral peptide analogs, process for the preparation thereof and pharmaceutical composition based thereon | |
| BRPI0618370A2 (en) | aerosol drug formulation, drug use and inhalation kit | |
| ME01333B (en) | Cladribine regimen for treating multiple sclerosis | |
| TW200720239A (en) | Styrylsulfonamides, their manufacture and use as pharmaceutical agents | |
| MX2009005125A (en) | Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents. | |
| TW200626149A (en) | Tricycles, their manufacture and use as pharmaceutical agents |